Cargando…

Early treatment with intravenous immunoglobulins in patients with critical illness polyneuropathy: a randomized controlled, double-blinded study

Detalles Bibliográficos
Autores principales:	Brunner, R, Rinner, W, Kitzberger, R, Sycha, T, Warszawska, J, Holzinger, U, Madl, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363725/ http://dx.doi.org/10.1186/cc10914

Ejemplares similares

Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and/or myopathy in patients with multiple organ failure and SIRS/sepsis: a prospective, randomized, placebo-controlled, double-blinded trial
por: Brunner, Richard, et al.
Publicado: (2013)

Impact of real-time continuous glucose monitoring on glucose variability in critically ill patients
por: Brunner, R, et al.
Publicado: (2010)

Pharmacokinetics of ranitidine during hemodiafiltration
por: Fuhrmann, V, et al.
Publicado: (2008)

Single-dose application of antithrombin III as alternative anticoagulation during extracorporeal therapy in critically ill patients with advanced liver cirrhosis: a retrospective data analysis
por: Brunner, R, et al.
Publicado: (2011)

Real-Time Continuous Glucose Monitoring in Critically Ill Patients: A prospective randomized trial
por: Holzinger, Ulrike, et al.
Publicado: (2010)

Pharmacokinetics and pharmacodynamics of esomeprazole and ranitidine during continuous venovenous hemodiafiltration
por: Fuhrmann, V, et al.
Publicado: (2013)

Critical illness polyneuropathy: incidence and risk factors
por: Meyer, B, et al.
Publicado: (2006)

Severity of electrophysiological alterations correlates with severity of illness in the early phase of critical illness polyneuropathy
por: Nemes, R, et al.
Publicado: (2012)

Effect of intravenous immunoglobulin in critically ill adult patients with sepsis: a meta-analysis
por: Turgeon, A, et al.
Publicado: (2006)

Determinants of critical illness polyneuropathy in the case of long-term ICU treatment
por: Klimasauskas, A, et al.
Publicado: (2009)

Implementing intensive insulin therapy in daily practice reduces the incidence of critical illness polyneuropathy and/or myopathy
por: Berends, N, et al.
Publicado: (2008)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

Efficacy and pharmacokinetics of intravenous paracetamol in the critically ill patient
por: Samson, AD, et al.
Publicado: (2009)

Intravenous paracetamol (Prodafalgan) causes hypotension in critically ill patients
por: Hersch, M, et al.
Publicado: (2004)

Impact of blood glucose on blood lactate levels in a medical ICU: a retrospective cohort study
por: Adelsmayr, G, et al.
Publicado: (2012)

Intravenous fosfomycin therapy in critically ill patients infected with colistin-resistant enterobacteriacae
por: Mukherjee, DN, et al.
Publicado: (2015)

Efficacy of glutamine dipeptide-supplemented total parenteral nutrition in critically ill patients: a prospective, double-blind randomized trial
por: Grau, TG, et al.
Publicado: (2008)

Use of Intravenous Immunoglobulin Therapy in a paediatric rheumatology service
por: Saladi, SM, et al.
Publicado: (2008)

Intravenous immunoglobulin therapy could have efficacy in severe sepsis
por: Kim, Ahmin, et al.
Publicado: (2013)

Use of intravenous immunoglobulin to treat sepsis in a general ICU
por: Drakeford, Y, et al.
Publicado: (2015)

Effect of low-dose intravenous dexamethasone on post lumbar discectomy pain: randomized and double blind study
por: Haghir, Amirhossein, et al.
Publicado: (2012)

Effect of increasing intravenous glucose load in the presence of normoglycemia on outcome and metabolism in critically ill rabbits
por: Derde, S, et al.
Publicado: (2009)

Point and trend accuracy of continuous glucose monitoring using intravenous microdialysis in critically ill patients
por: Leopold, JH, et al.
Publicado: (2015)

Intravenous immunoglobulins prevent breakdown of the blood-brain barrier in experimental sepsis
por: Esen, F, et al.
Publicado: (2010)

Levels of soluble fibrin in severe septic patients given intravenous immunoglobulin
por: Kobayashi, T, et al.
Publicado: (2009)

Intravenous immunoglobulins versus plasma exchange in the treatment of Guillain-Barré syndrome
por: Charra, B, et al.
Publicado: (2009)

Comparative study between intravenous immunoglobulins and standard treatment in septic patients
por: Hamed, G, et al.
Publicado: (2008)

Usefulness of intravenous immunoglobulin administration to sepsis-induced coagulopathy in ICU patients
por: Matsumoto, N, et al.
Publicado: (2014)

Glycemic variability and glucose complexity in critically ill patients: a retrospective analysis of continuous glucose monitoring data
por: Brunner, Richard, et al.
Publicado: (2012)

Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial
por: Van Eijk, MM, et al.
Publicado: (2011)

Peripheric arterial aneurisyms and monocytosis in intravenous immunoglobulin treatment resistant Kawasaki disease
por: Baskin, E, et al.
Publicado: (2008)

Use of intravenous and intramuscular immunoglobulin in the practice of treatment for purulent and septic deaths in newborns
por: Khanes, G, et al.
Publicado: (2012)

0716. Does intravenous iron induce oxydative stress in critically ill patients? A comparison with healthy volunteers
por: Lasocki, S, et al.
Publicado: (2014)

Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins
por: Mahdi-Rogers, Mohamed, et al.
Publicado: (2010)

Effect of intravenous administration of freeze-dried sulfonated human normal immunoglobulin for septic patients
por: Deguchi, Y, et al.
Publicado: (2009)

Acute exercise response in the critically ill
por: Collings, N, et al.
Publicado: (2013)

Cytokines associated with insulin resistance in critically ill patients
por: Omar, S, et al.
Publicado: (2007)

Epidemiology of transthyretin familial amyloid polyneuropathy in Portugal
por: Inês, Mónica, et al.
Publicado: (2015)

The rehabilitation in the management of Transthyretin Familial Amyloid Polyneuropathy
por: Morier, Agnès, et al.
Publicado: (2015)

Nasogastric feeding intolerance in the critically ill
por: OConnor, S, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_649no8bi1et1ijb8vaens61qvc